Prosight Management’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
6CM
Prosight Management's APTO Position: Q4 2021 in Review
Prosight Management sold out of Aptose Biosciences (APTO) in Q4 2021, closing a stake of 157 shares — an estimated $154K sold.
Prosight Management first reported a position in APTO in Q2 2020 and held it in 6 quarters. The position peaked at $6.84M in Q3 2020. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.
- Prosight Management reported no remaining Aptose Biosciences position as of Q4 2021 after selling out during the quarter.
- Prosight Management sold 157 Aptose Biosciences shares in Q4 2021, an estimated $154K.
- Prosight Management first reported a position in Aptose Biosciences in Q2 2020 and held it in 6 quarters.
- Prosight Management's Aptose Biosciences position peaked at $6.84M in Q3 2020.
- 58 funds tracked by Wall St. Rank held Aptose Biosciences as of Q4 2021.
Based on Prosight Management's 13F filing for Q4 2021, filed 14 Feb 2022.